PRNewswire

TAIPEI, Nov. 4, 2024 /PRNewswire/ — Formosa Pharmaceuticals, Inc. (6838.TW) reports completion and successful top-line results from CPN-303, a Phase 3 clinical study of APP13007 (GPN00833), conducted in Chinese cataract surgery patients by licensee, Grand Pharma (0512.HK).  APP13007, a novel

ATLANTA, Nov. 4, 2024 /PRNewswire/ — WHAT:With only hours remaining before the polls close on Election Day, November 5, 2024, the Georgia Coalition for the People’s Agenda (People’s Agenda), the National Coalition on Black Civic Participation (National Coalition), and other organiz

HONG KONG and SHANGHAI, Nov. 4, 2024 /PRNewswire/ — Ping An Insurance (Group) Company of China, Ltd. (hereafter “Ping An“, the “Company” or the “Group”, HKEX: 2318 / 82318; SSE: 601318) climbed 29 spots to 318th on Forbes World’s Best Employers 2024 li

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: